The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors | VuMedi

Insights from 2024 ASCO® GU Annual Meeting

The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors

By Insights from 2024 ASCO® GU Annual Meeting FEATURING Rana McKay

By Insights from 2024 ASCO® GU Annual Meeting FEATURING Rana McKay

0 views

April 15, 2024

Comments 0

Login to view comments. Click here to Login